Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement
Launched by UNIVERSITY OF AARHUS · Dec 9, 2022
Trial Information
Current as of January 21, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special exercise program designed to strengthen the hip compared to regular rehabilitation after hip replacement surgery. Specifically, it looks at patients who are having their first revision hip replacement surgery, which is when a previous hip replacement needs to be fixed or replaced. The goal is to see if this exercise program can help improve physical function, making it easier for patients to move around and do daily activities, compared to the usual care they would receive in the community.
To be eligible for this study, participants need to be at least 18 years old and motivated to join a 16-week exercise program. They should have undergone a specific type of hip surgery where parts of the hip joint (like the cup or stem) were replaced. However, those who use a wheelchair, are planning other leg surgeries soon, have a high body weight, or are currently receiving certain cancer treatments cannot participate. If chosen, participants will engage in the exercise program and will be tested on their physical abilities at the beginning and after 16 weeks to see how much they improve. This trial aims to find better ways to help patients recover after hip replacement surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing first revision THR
- • Age ≥ 18 years
- • Motivated to participate in an exercise program for 16 weeks
- • Provided informed consent to participate
- • Patients who has the cup and/or stem replaced or a combination of liner and caput replaced
- • Patients who can be baseline tested (chair stand test, stair climb test, 40m walking test)
- Exclusion Criteria:
- • Dependency of wheelchair
- • Preplanned other lower limb surgery within 12 months
- • Body Mass Index (BMI) score \> 40
- • Currently undergoing cancer treatment, e.g. chemo-, immuno-, or radiotherapy.
- • Comorbidities that prevent exercise
- • Inadequacy in written and spoken Danish
- • Mentally unable to participate
Trial Officials
Martin B Stisen, MSc
Principal Investigator
Aarhus University Hospital and Aarhus University
Inger Mechlenburg, Prof.
Study Director
Aarhus University Hospital and Aarhus University
Alma B Pedersen, Prof.
Study Director
Aarhus University Hospital and Aarhus University
Troels Kjeldsen, MSc
Study Director
Aarhus University Hospital and Aarhus University
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Odense, , Denmark
Vejle, , Denmark
Aarhus N, , Denmark
Aarhus, , Denmark
Viborg, , Denmark
Herning, , Denmark
Silkeborg, , Denmark
Hellerup, , Denmark
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials